133 related articles for article (PubMed ID: 2480794)
21. NAD(P)H: quinone oxidoreductase (DT-diaphorase) in chick embryo liver. Comparison to activity in rat and guinea pig liver and differences in co-induction with 7-ethoxyresorufin deethylase by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Spencer CB; Rifkind AB
Biochem Pharmacol; 1990 Jan; 39(2):327-35. PubMed ID: 2105732
[TBL] [Abstract][Full Text] [Related]
22. Quinoneimines as substrates for quinone reductase (NAD(P)H: (quinone-acceptor)oxidoreductase) and the effect of dicumarol on their cytotoxicity.
Powis G; See KL; Santone KS; Melder DC; Hodnett EM
Biochem Pharmacol; 1987 Aug; 36(15):2473-9. PubMed ID: 2440444
[TBL] [Abstract][Full Text] [Related]
23. The role of human and rodent DT-diaphorase in the reductive metabolism of hypoxic cell cytotoxins.
Walton MI; Sugget N; Workman P
Int J Radiat Oncol Biol Phys; 1992; 22(4):643-7. PubMed ID: 1544831
[TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationships for DT-diaphorase reduction of hypoxic cell directed agents: indoloquinones and diaziridinyl benzoquinones.
Bailey SM; Suggett N; Walton MI; Workman P
Int J Radiat Oncol Biol Phys; 1992; 22(4):649-53. PubMed ID: 1544832
[TBL] [Abstract][Full Text] [Related]
25. Phenobarbital-induced cytoprotective mechanisms in menadione metabolism: the role of glutathione reductase and DT-diaphorase.
Utley WS; Mehendale HM
Int J Biochem; 1990; 22(9):957-67. PubMed ID: 1704318
[TBL] [Abstract][Full Text] [Related]
26. Protection against reactive oxygen species by NAD(P)H: quinone reductase induced by the dietary antioxidant butylated hydroxyanisole (BHA). Decreased hepatic low-level chemiluminescence during quinone redox cycling.
Wefers H; Komai T; Talalay P; Sies H
FEBS Lett; 1984 Apr; 169(1):63-6. PubMed ID: 6201394
[TBL] [Abstract][Full Text] [Related]
27. The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)--I. Purification and properties of a nitroreductase enzyme from Escherichia coli--a potential enzyme for antibody-directed enzyme prodrug therapy (ADEPT).
Anlezark GM; Melton RG; Sherwood RF; Coles B; Friedlos F; Knox RJ
Biochem Pharmacol; 1992 Dec; 44(12):2289-95. PubMed ID: 1472094
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of rat liver NAD(P)H:quinone acceptor oxidoreductase (DT-diaphorase) by flavonoids isolated from the Chinese herb scutellariae radix (Huang Qin).
Liu XF; Liu ML; Iyanagi T; Legesse K; Lee TD; Chen SA
Mol Pharmacol; 1990 Jun; 37(6):911-5. PubMed ID: 1694261
[TBL] [Abstract][Full Text] [Related]
29. Direct protective effect of NAD(P)H:quinone reductase against menadione-induced chemiluminescence of postmitochondrial fractions of mouse liver.
Prochaska HJ; Talalay P; Sies H
J Biol Chem; 1987 Feb; 262(5):1931-4. PubMed ID: 2434474
[TBL] [Abstract][Full Text] [Related]
30. Relationship between DT-diaphorase-mediated metabolism of a series of aziridinylbenzoquinones and DNA damage and cytotoxicity.
Gibson NW; Hartley JA; Butler J; Siegel D; Ross D
Mol Pharmacol; 1992 Sep; 42(3):531-6. PubMed ID: 1406604
[TBL] [Abstract][Full Text] [Related]
31. Lapachol inhibition of DT-diaphorase (NAD(P)H:quinone dehydrogenase).
Preusch PC
Biochem Biophys Res Commun; 1986 Jun; 137(2):781-7. PubMed ID: 3089219
[TBL] [Abstract][Full Text] [Related]
32. Induction of 8-hydroxydeoxyguanosine but not initiation of carcinogenesis by redox enzyme modulations with or without menadione in rat liver.
Denda A; Sai KM; Tang Q; Tsujiuchi T; Tsutsumi M; Amanuma T; Murata Y; Nakae D; Maruyama H; Kurokawa Y
Carcinogenesis; 1991 Apr; 12(4):719-26. PubMed ID: 1707352
[TBL] [Abstract][Full Text] [Related]
33. The nature of DT-diaphorase (EC 1.6.99.2) activity in plasma membrane of astrocytes in primary cultures.
Malviya AN; Mandel P; Mersel M
Biochim Biophys Acta; 1986 Apr; 849(2):288-92. PubMed ID: 2421769
[TBL] [Abstract][Full Text] [Related]
34. Characterization of FMN-dependent NADH-quinone reductase induced by menadione in Escherichia coli.
Hayashi M; Hasegawa K; Oguni Y; Unemoto T
Biochim Biophys Acta; 1990 Aug; 1035(2):230-6. PubMed ID: 2118386
[TBL] [Abstract][Full Text] [Related]
35. Mitomycin C is not metabolized by but is an inhibitor of human kidney NAD(P)H: (quinone-acceptor)oxidoreductase.
Schlager JJ; Powis G
Cancer Chemother Pharmacol; 1988; 22(2):126-30. PubMed ID: 3136941
[TBL] [Abstract][Full Text] [Related]
36. Enhanced NAD(P)H:quinone reductase activity prevents glutamate toxicity produced by oxidative stress.
Murphy TH; De Long MJ; Coyle JT
J Neurochem; 1991 Mar; 56(3):990-5. PubMed ID: 1704427
[TBL] [Abstract][Full Text] [Related]
37. Vitamin K1 2,3-epoxide and quinone reduction: mechanism and inhibition.
Preusch PC; Smalley DM
Free Radic Res Commun; 1990; 8(4-6):401-15. PubMed ID: 2113031
[TBL] [Abstract][Full Text] [Related]
38. DT diaphorase and the cytotoxicity and mutagenicity of quinone-derived oxygen radicals.
Ernster L; Atallah AS; Hochstein P
Prog Clin Biol Res; 1986; 209A():353-63. PubMed ID: 2428049
[No Abstract] [Full Text] [Related]
39. Suggested mechanism for the modulation of the activity of NAD(P)H:quinone acceptor oxidoreductase (DT-diaphorase) by menadione: interpretation of the effect of menadione on 5'-[p-(Fluorosulfonyl)benzoyl]adenosine labeling of rat liver NAD(P)H:quinone acceptor oxidoreductase.
Chen S; Liu XF
Mol Pharmacol; 1992 Sep; 42(3):545-48. PubMed ID: 1406605
[TBL] [Abstract][Full Text] [Related]
40. Isolation and characterization of a mitomycin C-resistant variant of human colon carcinoma HT-29 cells.
Lee JH; Naito M; Nakajima M; Tsuruo T
Cancer Chemother Pharmacol; 1993; 33(3):215-20. PubMed ID: 7505723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
